Combining plasma p‐tau₂₃₁ and glial fibrillary acidic protein produces higher discriminative accuracy for amyloid positivity than other blood‐based biomarker combinations

Lifespan Trajectories of Asymmetry in White Matter Tracts

Characterizing amyloid and tau PET-based stages across the clinical continuum

A multi-ancestry polygenic risk score for Alzheimer disease is associated with cognitive decline, hippocampal atrophy and neuropathological hallmarks in diverse populations

Neuroimaging PheWAS and molecular phenotyping implicate <i>PSMC3</i> in Alzheimer's Disease

Genome‐wide pleiotropy analysis of longitudinal blood pressure and harmonized cognitive performance measures

Mild kidney dysfunction affects the predictive accuracy of blood‐based biomarkers for neuropsychological and neuroimaging outcomes over a 9 year follow‐up period

Evaluation of Deep Learning Algorithms to Predict Multiple Dementia-Related Neuropathologies from Brain MRI, Clinical and Genetic Data

Beyond NACC's Uniform Data Set for cognition: the impact of additional items on measurement precision

Five‐year change in sleep duration and incident Alzheimer's Disease and Related Dementias among lower‐income older adults

Scalable quality control on processing of large diffusion-weighted and structural magnetic resonance imaging datasets

The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging

BrainAge moderates associations between Alzheimer's disease biomarkers and cognitive decline: a meta-analysis across A4/LEARN, HABS and ADNI cohorts